Completed PHASE3 INTERVENTIONAL 2-arm NCT01665170

Pilot Study on the Efficacy of Pascoflair in an Acute Stressful Situation (TSST)

A Randomized, Double Blind, Placebo-controlled Pilot Study on the Efficacy of Passiflora Incarnata L. in an Acute Stressful Situation

Sponsor: Daacro

Conditions Healthy Stress

Interventions Passiflora incarnata Placebo

Updated 7 times since 2017 Last updated: Nov 4, 2015 Started: May 31, 2012 Primary completion: Aug 31, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01665170, this PHASE3 trial focuses on Healthy and Stress and remains completed. Sponsored by Daacro, it has been updated 7 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3
Jan 2021 — Dec 2022 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daacro
Pascoe Pharmazeutische Praeparate GmbH

Data source: Pascoe Pharmazeutische Praeparate GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Trier, Germany